Trials / Conditions / High Grade Fallopian Tube Serous Adenocarcinoma
High Grade Fallopian Tube Serous Adenocarcinoma
4 registered clinical trials studyying High Grade Fallopian Tube Serous Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients NCT05114421 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal NCT03924245 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Active Not Recruiting | Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cance NCT03943173 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Withdrawn | Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or NCT02756130 | Jonsson Comprehensive Cancer Center | Phase 1 / Phase 2 |